henhaobio
Sign in

The Lancet Infectious DiseasesMolecular BiologyPeer-reviewed journal article

Impact of JN.1 booster vaccination on neutralisation of SARS-CoV-2 variants KP.3.1.1 and XEC

Prerna AroraiD, Christine HappleiD, Amy Madeleine Kempf, Inga NehlmeieriD, Metodi V. StankoviD, Alexandra Dopfer‐JablonkaiD, Georg M. N. BehrensiD, Stefan PöhlmanniD, Markus HoffmanniD

PDFDOIPreprint

Abstract

The SARS-CoV-2 KP.3.1.1 lineage is currently the dominating lineage on several continents. In parallel, the XEC lineage, a recombinant of KS.1.1 and KP.3.3, is on track of becoming the next dominant lineage in Europe and North America. Here we performed a rapid virological characterisation of the XEC lineage and studied the impact of JN.1 mRNA booster vaccination on KP.3.1.1 and XEC neutralisation.

Citations
45
FWCI
15.60
Field percentile
top 1%

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Related papers

Similarity Map
SelectedSame fieldCross-field
THISLee '25Kaku '24Liu '24Wang '25Kaku '24Sano '24
79% semantic matchImmunology
Diana Wing Lee, Arshan Nasir, Sayda M. Elbashir+12 more·Vaccine·Mar 7, 2025· 16 citations